載入...
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
Amyloid-β (Aβ) and tau proteins currently represent the two most promising targets to treat Alzheimer's disease. The most extensively developed method to treat the pathologic forms of these proteins is through the administration of exogenous antibodies, or passive immunotherapy. In this review,...
Na minha lista:
| 發表在: | Neurobiol Dis |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Authors. Published by Elsevier Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7365083/ https://ncbi.nlm.nih.gov/pubmed/32682954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2020.105010 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|